| |
 |
|
Class Information
Number: 424/138.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.)
Description: Subject matter involving an antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an expression product or fragment thereof of a cancer-related gene, such as an oncogene or a proto-oncogene.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7622560 |
Monoclonal antibody specific for CD43 epitope |
Nov. 24, 2009 |
| 7619068 |
Ovr110 antibody compositions and methods of use |
Nov. 17, 2009 |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7615225 |
Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen |
Nov. 10, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| RE40948 |
APC antibodies |
Oct. 27, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7608264 |
Antibodies that bind to pleiotrophin growth factor receptor |
Oct. 27, 2009 |
| 7608259 |
Methods of cancer diagnosis and therapy targeted against a cancer stem line |
Oct. 27, 2009 |
| 7601355 |
Compositions and methods for altering immune function |
Oct. 13, 2009 |
| 7595047 |
Compositions and methods for promoting or inhibiting angiogenesis |
Sep. 29, 2009 |
| 7585505 |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
Sep. 8, 2009 |
| 7579187 |
Anti-A33 antibody |
Aug. 25, 2009 |
| 7576188 |
Antitumoral treatments |
Aug. 18, 2009 |
| 7560111 |
HER2 antibody composition |
Jul. 14, 2009 |
| 7553953 |
Chimeric, human and humanized anti-CSAp monoclonal antibodies |
Jun. 30, 2009 |
| 7550143 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
Jun. 23, 2009 |
| 7534428 |
Antibodies to tumor necrosis factor receptors 6.alpha. and 6.beta. |
May. 19, 2009 |
| 7531171 |
Antibodies to non-functional P2X.sub.7 receptor |
May. 12, 2009 |
| 7517967 |
Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
Apr. 14, 2009 |
| 7510710 |
Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor |
Mar. 31, 2009 |
| 7507724 |
Therapy-enhancing glucan |
Mar. 24, 2009 |
| 7507405 |
Antibody fragment-polymer conjugates and uses of same |
Mar. 24, 2009 |
| 7507404 |
Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Mar. 24, 2009 |
| 7504103 |
Methods of cancer diagnosis and therapy targeted against a cancer stem line |
Mar. 17, 2009 |
| 7498030 |
Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
Mar. 3, 2009 |
| 7498142 |
Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies |
Mar. 3, 2009 |
| 7485302 |
Treatment with anti-ErbB2 antibodies and chemotherapeutic agents |
Feb. 3, 2009 |
| 7476383 |
Antibody selective for DR4 and uses thereof |
Jan. 13, 2009 |
| 7476384 |
Death domain containing receptor 4 antibody and methods |
Jan. 13, 2009 |
| 7468184 |
Therapeutic agent for cachexia |
Dec. 23, 2008 |
| 7462607 |
Therapy-enhancing glucan |
Dec. 9, 2008 |
| 7459157 |
Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies |
Dec. 2, 2008 |
| 7455834 |
Methods and compositions for modulating and detecting WISP activity |
Nov. 25, 2008 |
| 7456262 |
Methods and composition for modulating and detecting wisp activity |
Nov. 25, 2008 |
| 7452538 |
Death domain containing receptor 4 antibodies and methods |
Nov. 18, 2008 |
| 7449184 |
Fixed dosing of HER antibodies |
Nov. 11, 2008 |
| 7445780 |
Antagonistic anti-CD40 antibodies |
Nov. 4, 2008 |
| 7445794 |
Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors |
Nov. 4, 2008 |
| 7435590 |
Monoclonal antibody and hybridoma producing the same |
Oct. 14, 2008 |
| 7435415 |
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
Oct. 14, 2008 |
| 7435412 |
Chronic lymphocytic leukemia cell line |
Oct. 14, 2008 |
| 7431926 |
Tumor supressor gene p33ING2 |
Oct. 7, 2008 |
| 7429382 |
Antibodies that bind cell-associated CA 125/O772P and methods of use thereof |
Sep. 30, 2008 |
| 7427400 |
Methods of cancer diagnosis and therapy targeted against a cancer stem line |
Sep. 23, 2008 |
| 7427399 |
Antibodies and related molecules that bind to 161P2F10B proteins |
Sep. 23, 2008 |
| 7413736 |
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
Aug. 19, 2008 |
| 7399468 |
Diagnostic and therapeutic use of antibodies against the urokinase receptor |
Jul. 15, 2008 |
| 7399469 |
Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer |
Jul. 15, 2008 |
| 7390486 |
PRO4381 antibodies |
Jun. 24, 2008 |
|
|
|
